These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17342780)

  • 1. Opposing short- and long-term effects on muscarinic M1/4 receptor binding following chronic phencyclidine treatment.
    Newell KA; Zavitsanou K; Huang XF
    J Neurosci Res; 2007 May; 85(6):1358-63. PubMed ID: 17342780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perinatal PCP treatment alters the developmental expression of prefrontal and hippocampal muscarinic receptors.
    du Bois TM; Newell KA; Han M; Deng C; Huang XF
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):37-40. PubMed ID: 18940225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid cortico-limbic alterations in AMPA receptor densities after administration of PCP: implications for schizophrenia.
    Zavitsanou K; Nguyen V; Newell K; Ballantyne P; Huang XF
    J Chem Neuroanat; 2008 Oct; 36(2):71-6. PubMed ID: 18640263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short and long term changes in NMDA receptor binding in mouse brain following chronic phencyclidine treatment.
    Newell KA; Zavitsanou K; Huang XF
    J Neural Transm (Vienna); 2007; 114(8):995-1001. PubMed ID: 17401537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of locomotor activity by chronic phencyclidine is associated with an increase in striatal NMDA receptor function and an upregulation of the NR1 receptor subunit.
    Hanania T; Hillman GR; Johnson KM
    Synapse; 1999 Mar; 31(3):229-39. PubMed ID: 10029241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.
    Nabeshima T; Mouri A; Murai R; Noda Y
    Ann N Y Acad Sci; 2006 Nov; 1086():160-8. PubMed ID: 17185514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of NMDA receptor inhibition by phencyclidine on the neuronal differentiation of PC12 cells.
    Lee E; Williams Z; Goodman CB; Oriaku ET; Harris C; Thomas M; Soliman KF
    Neurotoxicology; 2006 Jul; 27(4):558-66. PubMed ID: 16580729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypofunctional glutamatergic neurotransmission in the prefrontal cortex is involved in the emotional deficit induced by repeated treatment with phencyclidine in mice: implications for abnormalities of glutamate release and NMDA-CaMKII signaling.
    Murai R; Noda Y; Matsui K; Kamei H; Mouri A; Matsuba K; Nitta A; Furukawa H; Nabeshima T
    Behav Brain Res; 2007 Jun; 180(2):152-60. PubMed ID: 17451820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of N-methyl-D-aspartate receptors by phencyclidine causes the loss of corticostriatal neurons.
    Wang C; Anastasio N; Popov V; Leday A; Johnson KM
    Neuroscience; 2004; 125(2):473-83. PubMed ID: 15062989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high n-6 polyunsaturated fatty acid diet reduces muscarinic M2/M4 receptor binding in the rat brain.
    du Bois TM; Bell W; Deng C; Huang XF
    J Chem Neuroanat; 2005 Jun; 29(4):282-8. PubMed ID: 15927789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subchronic phencyclidine in rats: alterations in locomotor activity, maze performance, and GABA(A) receptor binding.
    Beninger RJ; Beuk J; Banasikowski TJ; van Adel M; Boivin GA; Reynolds JN
    Behav Pharmacol; 2010 Feb; 21(1):1-10. PubMed ID: 19949321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simvastatin reverses the downregulation of M1/4 receptor binding in 6-hydroxydopamine-induced parkinsonian rats: the association with improvements in long-term memory.
    Wang Q; Wei X; Gao H; Li J; Liao J; Liu X; Qin B; Yu Y; Deng C; Tang B; Huang XF
    Neuroscience; 2014 May; 267():57-66. PubMed ID: 24613723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline temperature in an animal model of schizophrenia: long-term effects of perinatal phencyclidine administration.
    Radonjić NV; Petronijević ND; Vucković SM; Prostran MS; Nesić ZI; Todorović VR; Paunović VR
    Physiol Behav; 2008 Feb; 93(3):437-43. PubMed ID: 17996259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excitatory and inhibitory neurotransmission is chronically altered following perinatal NMDA receptor blockade.
    du Bois TM; Deng C; Han M; Newell KA; Huang XF
    Eur Neuropsychopharmacol; 2009 Apr; 19(4):256-65. PubMed ID: 19150227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment.
    Mouri A; Noda Y; Enomoto T; Nabeshima T
    Neurochem Int; 2007; 51(2-4):173-84. PubMed ID: 17669558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic phencyclidine (PCP)-induced modulation of muscarinic receptor mRNAs in rat brain: impact of antipsychotic drug treatment.
    Steward LJ; Kennedy MD; Morris BJ; Pratt JA
    Neuropharmacology; 2012 Mar; 62(3):1554-63. PubMed ID: 21640736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of single and repeated phencyclidine administration on [3H]flunitrazepam binding in rat brain.
    Abe S; Suzuki T; Endo K; Hori T; Arai H
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):133-40. PubMed ID: 15610955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased density of muscarinic receptors in the superior temporal gyrusin schizophrenia.
    Deng C; Huang XF
    J Neurosci Res; 2005 Sep; 81(6):883-90. PubMed ID: 16041805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuropsychopharmacological study on an animal model for negative symptom of schizophrenia induced by repeated phencyclidine treatment].
    Noda Y; Nabeshima T
    Yakugaku Zasshi; 2000 Aug; 120(8):677-82. PubMed ID: 10946617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-evaluation of phencyclidine low-affinity or "non-NMDA" binding sites.
    Hirbec H; Mausset AL; Kamenka JM; Privat A; Vignon J
    J Neurosci Res; 2002 May; 68(3):305-14. PubMed ID: 12111860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.